<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03489330</url>
  </required_header>
  <id_info>
    <org_study_id>MWU3004_STU00205629</org_study_id>
    <nct_id>NCT03489330</nct_id>
  </id_info>
  <brief_title>Antibiotic Outbreak, Risk Factors for Never Event, Prediction of Inappropriate Use</brief_title>
  <official_title>A Retrospective Study to Understand the Risk Factors/Drivers of &quot;Inappropriate&quot; Antimicrobial Use and the Performance Evaluation of a Clinical Decision Support Tool That Facilitates Prediction of Outbreaks of Inappropriate Antibiotic Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Midwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Northwestern Memorial Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Michigan</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henry Ford Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Wayne State University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Midwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In order to decrease inappropriate antibiotic use, drivers of inappropriate use must be
      identified locally. This study will focus on the MOST inappropriate use, which are defined as
      'never events'. Previous work has shown that antibiotic use clusters over time. It is
      hypothesized that never events also cluster over time. Using electronic data capture
      strategies, an algorithm will be developed to quickly and accurately identify areas of
      antibiotic use concern. Secondly, a framework will be developed, utilizing antimicrobial
      consumption data and captured signals of inappropriate antimicrobial use to provide targets
      for antimicrobial stewardship efforts.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Appropriateness in antimicrobial prescribing has become a focal national and international
      issue. It has been estimated that upwards of 50% of antibiotic use is inappropriate. With
      this backdrop, a national strategic goal has been set by the United States White House to
      decrease inappropriate antibiotic use by 20% and 50%, respectively for inpatient and
      outpatient settings. In order to decrease inappropriate use, drivers of incorrect use must be
      identified at each local setting. The actual drivers of confirmed inappropriate use have been
      difficult to identify except when using time and resource intense chart reviews. Even the
      largest contemporary antibiotic consumption studies have not assessed appropriateness as it
      was 'outside of study scope'. Further, there is no consensus or agreement on what constitutes
      inappropriate use. These apparent omissions underscore the difficulty and complexity in
      attributing appropriateness of use for antimicrobials. Importantly, this study will focus on
      the MOST inappropriate use, which are defined as 'never events'. Previous work has shown that
      antibiotic use clusters over time. It is hypothesized that never events also cluster over
      time. Using electronic data capture strategies, an algorithm will be developed to quickly and
      accurately identify areas of antibiotic use concern. Secondly, a framework will be developed,
      utilizing antimicrobial consumption data and captured signals of inappropriate antimicrobial
      use to provide targets for antimicrobial stewardship efforts.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">January 1, 2014</start_date>
  <completion_date type="Anticipated">February 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>appropriateness of vancomycin use</measure>
    <time_frame>Proposed 36 month study period</time_frame>
    <description>classified as 1) never event, 2) potentially inappropriate, 3) not inappropriate</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>outbreaks of never events</measure>
    <time_frame>Proposed 36 month study period</time_frame>
    <description>predictive interval thresholds that identify high proportion of never events</description>
  </secondary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Infectious Disease</condition>
  <arm_group>
    <arm_group_label>Northwestern Memorial Hospital data</arm_group_label>
    <description>Inpatient intravenous vancomycin use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Henry Ford Hospital data</arm_group_label>
    <description>Inpatient intravenous vancomycin use</description>
  </arm_group>
  <arm_group>
    <arm_group_label>University of Michigan Hospital data</arm_group_label>
    <description>Inpatient intravenous vancomycin use</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        The retrospective study population will be based on all inpatient intravenous vancomycin
        used during the proposed 36-month study period. Patient level data that identifies adults
        unable to consent, individuals who are not yet adults, pregnant women, or prisoners will
        not be collected.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  receipt of inpatient intravenous vancomycin during proposed study period

          -  adults 18 years of age or older and less than 90 years of age

        Exclusion Criteria:

          -  individuals who are not yet adults (infants, children, teenagers)

          -  pregnant women

          -  prisoners
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marc H Scheetz, PharmD, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Midwestern University</name>
      <address>
        <city>Downers Grove</city>
        <state>Illinois</state>
        <zip>60515</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://psnet.ahrq.gov/primers/primer/3/never-events</url>
  </link>
  <link>
    <url>https://www.cdc.gov/drugresistance/pdf/carb_national_strategy.pdf</url>
  </link>
  <reference>
    <citation>Scheetz MH, Crew PE, Miglis C, Gilbert EM, Sutton SH, O'Donnell JN, Postelnick M, Zembower T, Rhodes NJ. Investigating the Extremes of Antibiotic Use with an Epidemiologic Framework. Antimicrob Agents Chemother. 2016 May 23;60(6):3265-9. doi: 10.1128/AAC.00572-16. Print 2016 Jun.</citation>
    <PMID>27001807</PMID>
  </reference>
  <reference>
    <citation>P.R. Yarnold, R.C. Soltysik, Refining two-group multivariable classification models using univariate optimal discriminant analysis., Decision Sciences, 22 (1991) 1158-1164.</citation>
  </reference>
  <reference>
    <citation>P.R. Yarnold, R.C. Soltysik, Maximizing Predictive Accuracy, ODA Books2016.</citation>
  </reference>
  <reference>
    <citation>Rhodes NJ, O'Donnell JN, Lizza BD, McLaughlin MM, Esterly JS, Scheetz MH. Tree-Based Models for Predicting Mortality in Gram-Negative Bacteremia: Avoid Putting the CART before the Horse. Antimicrob Agents Chemother. 2015 Nov 23;60(2):838-44. doi: 10.1128/AAC.01564-15. Print 2016 Feb.</citation>
    <PMID>26596934</PMID>
  </reference>
  <reference>
    <citation>Cusini A, Rampini SK, Bansal V, Ledergerber B, Kuster SP, Ruef C, Weber R. Different patterns of inappropriate antimicrobial use in surgical and medical units at a tertiary care hospital in Switzerland: a prevalence survey. PLoS One. 2010 Nov 16;5(11):e14011. doi: 10.1371/journal.pone.0014011.</citation>
    <PMID>21103362</PMID>
  </reference>
  <reference>
    <citation>Glowacki RC, Schwartz DN, Itokazu GS, Wisniewski MF, Kieszkowski P, Weinstein RA. Antibiotic combinations with redundant antimicrobial spectra: clinical epidemiology and pilot intervention of computer-assisted surveillance. Clin Infect Dis. 2003 Jul 1;37(1):59-64. Epub 2003 Jun 23.</citation>
    <PMID>12830409</PMID>
  </reference>
  <reference>
    <citation>Hecker MT, Aron DC, Patel NP, Lehmann MK, Donskey CJ. Unnecessary use of antimicrobials in hospitalized patients: current patterns of misuse with an emphasis on the antianaerobic spectrum of activity. Arch Intern Med. 2003 Apr 28;163(8):972-8.</citation>
    <PMID>12719208</PMID>
  </reference>
  <reference>
    <citation>Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA. Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011. JAMA. 2016 May 3;315(17):1864-73. doi: 10.1001/jama.2016.4151.</citation>
    <PMID>27139059</PMID>
  </reference>
  <reference>
    <citation>Kelesidis T, Braykov N, Uslan DZ, Morgan DJ, Gandra S, Johannsson B, Schweizer ML, Weisenberg SA, Young H, Cantey J, Perencevich E, Septimus E, Srinivasan A, Laxminarayan R. Indications and Types of Antibiotic Agents Used in 6 Acute Care Hospitals, 2009-2010: A Pragmatic Retrospective Observational Study. Infect Control Hosp Epidemiol. 2016 Jan;37(1):70-9. doi: 10.1017/ice.2015.226. Epub 2015 Oct 12.</citation>
    <PMID>26456803</PMID>
  </reference>
  <reference>
    <citation>Magill SS, Edwards JR, Beldavs ZG, Dumyati G, Janelle SJ, Kainer MA, Lynfield R, Nadle J, Neuhauser MM, Ray SM, Richards K, Rodriguez R, Thompson DL, Fridkin SK; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. JAMA. 2014 Oct 8;312(14):1438-46. doi: 10.1001/jama.2014.12923.</citation>
    <PMID>25291579</PMID>
  </reference>
  <reference>
    <citation>Baggs J, Fridkin SK, Pollack LA, Srinivasan A, Jernigan JA. Estimating National Trends in Inpatient Antibiotic Use Among US Hospitals From 2006 to 2012. JAMA Intern Med. 2016 Nov 1;176(11):1639-1648. doi: 10.1001/jamainternmed.2016.5651.</citation>
    <PMID>27653796</PMID>
  </reference>
  <reference>
    <citation>Rhodes NJ, Wagner JL, Gilbert EM, Crew PE, Davis SL, Scheetz MH. Days of Therapy and Antimicrobial Days: Similarities and Differences Between Consumption Metrics. Infect Control Hosp Epidemiol. 2016 Aug;37(8):971-3. doi: 10.1017/ice.2016.109. Epub 2016 May 13.</citation>
    <PMID>27174570</PMID>
  </reference>
  <reference>
    <citation>The World Health Organization. Health Topics: Disease Outbreaks, 2015.</citation>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2018</study_first_submitted>
  <study_first_submitted_qc>April 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 5, 2018</study_first_posted>
  <last_update_submitted>April 3, 2018</last_update_submitted>
  <last_update_submitted_qc>April 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Anti-Bacterial Agents/therapeutic use</keyword>
  <keyword>Drug Utilization/statistics &amp; numerical data</keyword>
  <keyword>Hospitals/statistics &amp; numerical data</keyword>
  <keyword>Data Analysis, Statistical</keyword>
  <keyword>Interpretation, Statistical Data</keyword>
  <keyword>Antibiotic Stewardship</keyword>
  <keyword>Electronic Medical Record</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>All files containing patient identifiers will be de-identified before sharing across study sites.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

